Where We Stand Position Statements

  The Academy of Managed Care Pharmacy (AMCP) opposes any willing provider pharmacy legislation. AMCP supports the ability of managed care organizations to selectively contract with only those providers necessary to enable the organization to provide patients with adequate access to

  Where We Stand on Appropriate Uses of Prescription Information by Managed Care Organizations The Academy of Managed Care Pharmacy (AMCP) believes that prescription information, whether individually identifiable by patient or prescriber or aggregated without identifying specific individuals, should be

  Where We Stand on Behind the Counter Drugs   The Academy of Managed Care Pharmacy (AMCP) supports the establishment of a class of drugs that would allow consumers, with the intervention of a pharmacist, to purchase certain medications without

  Where We Stand on the Best Price Requirements of the Medicaid Rebate Program The Academy of Managed Care Pharmacy (AMCP) believes that to provide the greatest value to Americans who need prescription drugs, market forces must effectively ensure that

Where We Stand on Biosimilar Drug Therapies The Academy of Managed Care Pharmacy (AMCP) supports an abbreviated licensure pathway for the approval of biosimilar biologic drug therapies1 by the U.S. Food and Drug Administration (FDA). Biological products2 are certain to play an increasingly important role in the country

 AMCP supports the concept of collaborative drug therapy management (CDTM), a formal partnership between a pharmacist and a prescriber that allows the pharmacist to manage a patient’s drug therapy.

AMCP supports scientifically sound research that compares the effectiveness and value of prescription drugs, as well as research aimed at tailoring treatment options to individual patients’ needs.

The Academy of Managed Care Pharmacy (AMCP) supports compensation for Pharmaceutical Care Services (which may also be referred to as medication therapy management, drug therapy management, pharmacist's care, or collaborative practice) when rendered by pharmacists and other qualified health care

  The Academy of Managed Care Pharmacy (AMCP) believes that a health care delivery system that is based upon an open and competitive marketplace will provide greater value to patients and payers than a system that is one size fits

The Academy of Managed Care Pharmacy (AMCP) discourages the use of direct to consumer advertising that promotes specific prescription drug products, but supports ads that educate the public about disease symptoms and available treatment options.   Direct to Consumer Advertising

 Where We Stand on Electronic Communication of Prescription Information   The Academy of Managed Care Pharmacy (AMCP) supports the utilization of electronic prescription information, provided that there are reasonable and reliable assurances of authenticity, accountability, accuracy and confidentiality. AMCP believes

  The Academy of Managed Care Pharmacy (AMCP) supports the implementation and expanded use of electronic health information technology, including electronic health records 1 and electronic prescribing 2 , provided that there are appropriate mechanisms in place to protect the

  Where We Stand on Formularies The Academy of Managed Care Pharmacy (AMCP) supports the use of evidence based formularies that enhance quality of pharmaceutical care while lowering medication costs.   A drug formulary is a continually updated list of

  Where We Stand on Fraud, Waste and Abuse in the Medicare Part D Prescription Drug Benefit  The Academy of Managed Care Pharmacy (AMCP) is deeply concerned about reports of fraud, waste and abuse within the Medicare Part D prescription

  The Academy of Managed Care Pharmacy (AMCP) encourages the use of generic 1 drugs as safe, cost effective alternatives to the equivalent brand name products. 2 Generic drugs are approved by the U.S. Food and Drug Administration (FDA).When a

  Where We Stand on Government Regulation of Prescription Drug Pricing The Academy of Managed Care Pharmacy (AMCP) believes that government regulation of prescription drug pricing, regardless of its structure, would have an overall negative impact on consumer cost, quality,

  Where We Stand on Government Mandated Pharmacy Benefits The Academy of Managed Care Pharmacy (AMCP) believes managed care organizations (MCOs) and their clients (e.g. individuals, employers, government) must be able to independently make decisions regarding health benefits in order

  The Academy of Managed Care Pharmacy (AMCP) supports a medication error reporting system that encourages participation and provides confidentiality and protection of the information reported and the person(s) reporting. Additionally, this system should establish processes to detect and correct

  The Academy of Managed Care Pharmacy (AMCP) opposes legislation that restricts the appropriate generic substitution of narrow therapeutic index (NTI) drugs. A drug is commonly referred to as having a narrow therapeutic index when small variances in blood levels cause

  The Academy of Managed Care Pharmacy supports off label use of FDA approved drugs when medically appropriate and necessary, but opposes government mandated coverage of specific pharmaceuticals, whether for FDA approved or off label uses. Off label use means

The Academy of Managed Care Pharmacy (AMCP) supports protection of patient confidentiality and endorses the responsible use of patient identifiable medical and prescription drug information by authorized pharmacists, physicians, and other health care professionals. Patients must be assured that their

The Academy of Managed Care Pharmacy (AMCP) recognizes and supports the concept that all patients (and their caregivers) should have certain healthcare rights that assure confidentiality of healthcare services,1 provide access to high quality healthcare, and allow access to information with which they may make informed decisions regarding their medication therapy and healthcare choices.

AMCP supports the inclusion of prescription drug coverage in all health care benefit programs, including those administered by government agencies (e.g. Medicare, Medicaid and health insurance exchanges). Appropriate access to and use of prescription medications promotes both patient well-being and the efficient use of medical resources. 

  AMCP has concern with legislative proposals that would allow the importation of prescription drugs for resale in the United States. AMCP understands that such proposals are being offered to address the plight of individuals unable to afford much needed

  Where We Stand on Regulation of Pharmacy Benefit Managers (PBMs)   The Academy of Managed Care Pharmacy believes that government should encourage an environment in which pharmacists working within managed care organizations, including pharmaceutical benefit management companies, can continue

  The Academy of Managed Care Pharmacy (AMCP) supports the use of therapeutic interchange programs as a part of a comprehensive approach to quality, cost effective patient care.   Therapeutic interchange is the practice of replacing, with the prescribing physician's

  "The current health care systems cannot do the job. Trying harder will not work. If we want safer, higher quality care, we will need to have redesigned systems of care, including the use of information technology to support clinical

The Academy's Where We Stand series represents the position statements that AMCP has taken over the years on a wide range of managed care pharmacy topics. AMCP's position statements are regularly reviewed and updated.